Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?

Publication date: Available online 15 February 2019Source: Journal of Clinical and Experimental HepatologyAuthor(s): Narendra S. Choudhary, Ajay DusejaNonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Patients with NAFLD are at a higher risk of developing cardiovascular disease (CVD). In fact, CVD-related mortality is more common in patients with NAFLD in comparison to liver-related mortality. This association is related to the common metabolic risk factors such as obesity, dyslipidemia, diabetes, and hypertension shared by both NAFLD and CVD, and also there is independent association of NAFLD with CVD because of risk factors such as insulin resistance, systemic inflammation, and atherogenic dyslipidemia. While there is abundant literature on association of NAFLD with CVD, there is sparse literature regarding the screening for CVD in patients with NAFLD. In the current review article, we discuss as to which patients with NAFLD to screen and how to screen for CVD.

Source: Journal of Clinical and Experimental Hepatology - March 8, 2019 Category: Gastroenterology Source Type: research